SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-05-042834
Filing Date
2005-03-04
Accepted
2005-03-04 17:12:27
Documents
11
Period of Report
2004-12-31

Document Format Files

Seq Description Document Type Size
1 FOR THE FISCAL YEAR ENDED DECEMBER 31, 2004 d10k.htm 10-K 1423262
2 EMPLOYEE STOCK PURCHASE PLAN dex1086.htm EX-10.86 51132
3 SEVERANCE AGREEMENT dex10162.htm EX-10.162 40126
4 NON-EMPLOYEE DIRECTOR COMPENSATION, AMENDED AND RESTATED dex10209.htm EX-10.209 5493
5 LEASE AGREEMENT dex10212.htm EX-10.212 390114
6 SUBSIDIARIES OF THE REGISTRANT dex21.htm EX-21 32081
7 CONSENT OF DELOITTE & TOUCHE LLP dex231.htm EX-23.1 1570
8 SECTION 302 CEO CERTIFICATION dex311.htm EX-31.1 9423
9 SECTION 302 CFO CERTIFICATION dex312.htm EX-31.2 9617
10 SECTION 906 CEO CERTIFICATION dex321.htm EX-32.1 3026
11 SECTION 906 CFO CERTIFICATION dex322.htm EX-32.2 3008
  Complete submission text file 0001193125-05-042834.txt   1971711
Mailing Address 3151 SOUTH 17TH ST WILMINGTON NC 28412
Business Address 3151 SOUTH 17TH ST WILMINGTON NC 28412 9102510081
PHARMACEUTICAL PRODUCT DEVELOPMENT INC (Filer) CIK: 0001003124 (see all company filings)

IRS No.: 561640186 | State of Incorp.: NC | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-27570 | Film No.: 05662025
SIC: 8731 Services-Commercial Physical & Biological Research